Econ Financial Services’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.13M Buy
36,280
+5,981
+20% +$532K 1.31% 31
2026
Q2
$2.74M Buy
+30,299
New +$2.54M 1.28% 35
2026
Q1
– Sell
-22,073
Closed -$1.88M – 78
2025
Q4
$1.88M Sell
22,073
-5,125
-19% -$421K 0.94% 45
2025
Q3
$2.12M Buy
27,198
+15,836
+139% +$1.24M 1.05% 36
2025
Q2
$889K Buy
+11,362
New +$847K 0.46% 56

Other funds holding EW

Econ Financial Services's EW Position: Q3 2026 in Review

Econ Financial Services increased its Edwards Lifesciences (EW) stake by 20% in Q3 2026, buying an estimated $532K and bringing the position to 36,280 shares worth $3.13M. The position accounts for 1.31% of the portfolio, ranked #31.

Econ Financial Services first reported a position in EW in Q2 2025 and has held it in 5 quarters since. 492 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Econ Financial Services held 36,280 shares of Edwards Lifesciences worth $3.13M as of Q3 2026.
  • Econ Financial Services bought 5,981 Edwards Lifesciences shares in Q3 2026, an estimated $532K.
  • Edwards Lifesciences made up 1.31% of Econ Financial Services's portfolio in Q3 2026, its #31 holding.
  • Econ Financial Services first reported a position in Edwards Lifesciences in Q2 2025 and has held it in 5 quarters since.
  • 492 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Econ Financial Services's 13F filing for Q3 2026, filed 19 Oct 2026.